MENAGEN

We're thrilled to share the official recap of #Menagen grand opening event. Witness the glorious culmination of years of dedication and the dawn of a new era in #healthcare. Menagen is on the verge of transforming healthcare in the #region, and this event marks the beginning of a remarkable journey. Watch the video now and be part of the story! #Menagen #GrandOpening #InnovationInHealthcare #HealthcareForTomorrow

#HereditaryAngioedema (#HAE) is a rare genetic disorder that causes sudden and severe swelling in different parts of the body, including the #hands, #feet, #face, and #throat. Unlike more common forms of swelling, #HAEattacks can occur without warning and may become life-threatening, especially if they affect the airways. HAE results from a deficiency or dysfunction of a #protein involved in regulating blood vessels, which leads to unpredictable swelling episodes. Managing HAE often requires lifelong treatment to prevent attacks and manage symptoms during an acute episode. While #HAE affects a small percentage of the population, its impact on those who suffer from it is profound, making it essential to spread awareness about early diagnosis and proper treatment. #Menagen #Pharma #HAEAwareness #RareDisease #GeneticDisorders #MedicalResearch #HealthCare #LivingWithHAE

Visit us at #CPHIMiddleEast 2024! The premier pharma event in the region. #Menagen #CPHI #Pharma

#LiverCancer is a serious and often aggressive form of #cancer that begins in the cells of the liver. The most common type is #HepatocellularCarcinoma, which typically starts in #hepatocytes, the primary cells of the liver. Liver cancer can be difficult to detect in its early stages because symptoms often do not appear until the disease has progressed. Factors that increase the risk of developing liver cancer include chronic #HepatitisB or #HepatitisC infections, #cirrhosis, heavy #alcohol consumption, and exposure to #aflatoxins. Symptoms may include weight loss, loss of appetite, #jaundice, and abdominal pain. Early detection and treatment are crucial for improving outcomes, and options may include surgery, #livertransplant, chemotherapy, and targeted therapies. It's crucial to highlight that liver cancer is one of the fastest-growing cancer diagnoses in the world. This makes #LiverCancerAwarenessMonth an essential time to raise awareness and promote early detection. #Menagen #Pharma #CancerAwareness #HealthAwareness #CancerResearch #LiverHealth #Oncology #CancerTreatment

At Menagen, we stand with the warriors, the survivors, and those who fight alongside them in the battle against breast cancer. Early detection saves lives! This month, let's come together to raise awareness, support ongoing research, and encourage everyone to prioritize their health. Whether it’s scheduling a mammogram, sharing resources, or wearing pink — every action counts. 🎗️ #BreastCancerAwarenessMonth #PinkOctober #Menagen #EarlyDetectionSavesLives

Marginal Zone Lymphoma (MZL) is a rare type of non-Hodgkin lymphoma that originates in the marginal zone, an area of the lymphoid tissue where B-cells are located. These B-cells, which are part of the immune system, become abnormal and multiply uncontrollably, leading to the development of tumors. MZL can affect various parts of the body, including the lymph nodes, spleen, and other organs. Unlike more common types of lymphoma, Marginal Zone Lymphoma often progresses slowly, and symptoms may not appear until the disease is more advanced. Common signs include swollen lymph nodes, fatigue, weight loss, and night sweats. Treatment for MZL varies depending on the stage and location of the disease, ranging from watchful waiting to targeted therapies and immunotherapy. Did you know that Marginal Zone Lymphoma is one of the lesser-known types of lymphoma, yet it still poses significant challenges for those affected? #Menagen #Pharma #MarginalZoneLymphoma #MZL #LymphomaAwareness #RareCancer #NonHodgkinLymphoma #CancerResearch #BCells #Immunotherapy #CancerSupport #HealthAwareness #LymphomaTreatment

Lungs, the essential organs responsible for exchanging gases in the human body, are increasingly under threat from multiple factors such as smoking, pollution, respiratory infections, etc Five respiratory diseases are the most typical causes of sickness and death worldwide such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, acute respiratory tract infection and tuberculosis (TB). The burden of these respiratory conditions is high in low-to-middle-income countries, which are aggravated by smoking, air pollution and climate change. World Lung Day acts as an essential medium to emphasise healthy lungs, the pressing need to identify, prevent and treat several lung conditions and increase awareness regarding lung illnesses, promote lung health and support improved healthcare access. #Menagen #Lung #Lungcancer #WorldLungDay #Health #Awareness

Cystic fibrosis (#CF) is a genetic disorder that leads to the accumulation of thick, sticky mucus in various organs, primarily affecting the lungs and digestive tract. This buildup results from mutations in the #CFTRgene, which disrupts the regulation of salt and water transport across cell membranes. As a consequence, individuals with #cysticfibrosis often experience chronic lung infections due to blocked airways, as well as difficulties absorbing nutrients because of #pancreaticinsufficiency. Symptoms may include persistent coughs, wheezing, difficulty breathing, and poor growth or weight gain. While there is no cure for #cysticfibrosis, several treatments are available. These include inhaled medications to thin mucus; antibiotics to fight infections; enzyme supplements for better digestion; and advanced therapies like #geneediting aimed at addressing the underlying cause. Despite advancements in treatment options improving quality of life significantly, those affected typically face a reduced life expectancy compared to healthy individuals. #Menagen #Pharma #CysticFibrosis #CFTRMutation #PancreaticInsufficiency #GeneTherapy #ChronicIllness #LungHealth #GeneticDisorder #HealthCare #MedicalResearch

Chronic Myelogenous Leukemia (CML) is a type of #cancer that begins in the #boneMarrow due to a genetic mutation affecting blood cell production. The most distinctive feature of CML is the overproduction of abnormal white blood cells, which can accumulate and disrupt normal blood cell function, leading to various symptoms and health complications. Unlike more common forms of #leukemia, CML typically progresses slowly and may not show symptoms in its early stages. However, as the disease advances, it can cause fatigue, anemia, frequent infections, and an enlarged spleen. Managing CML often involves targeted therapies that address the underlying genetic mutation, helping to control the disease and improve quality of life. While treatments can help manage #CML, a comprehensive, long-term approach is essential for effective care. This involves regular monitoring, medication, and support to maintain a high quality of life for those affected by this chronic condition. #Menagen #pharma #ChronicMyelogenousLeukemia #CancerCare #HealthManagement #BloodDisorders

Menagen is thrilled to announce our latest partnership with Pharmosa Biopharm to bring a cutting-edge sustained-release inhaled treprostinil product to the #MENAT region. This collaboration marks a significant step forward in providing advanced treatment options for patients with pulmonary arterial hypertension (#PAH). Read the full article here: https://lnkd.in/dXfrs6gu #Menagen #Pharma #HealthcareInnovation #Partnership #PulmonaryHypertension #Pharmaceuticals #MENAT